A psychedelic drug which causes half-an-hour trips has shown some success in treating depression, early trial results suggest. Early evidence from a small trial suggests the powerful pharmaceutical-grade hallucinogenic – known as intravenous DMT, or SPL026 – could improve symptoms of moderate to severe depression when used in conjunction with therapy. According to un-peer reviewed…

Continue Reading